tolvaptan has been researched along with (6-chloro-1-(2-(dimethylamino)ethyl)indol-3-yl)-spiro(1h-isobenzofuran-3,4'-piperidine)-1'-yl-methanone in 1 studies
Studies (tolvaptan) | Trials (tolvaptan) | Recent Studies (post-2010) (tolvaptan) | Studies ((6-chloro-1-(2-(dimethylamino)ethyl)indol-3-yl)-spiro(1h-isobenzofuran-3,4'-piperidine)-1'-yl-methanone) | Trials ((6-chloro-1-(2-(dimethylamino)ethyl)indol-3-yl)-spiro(1h-isobenzofuran-3,4'-piperidine)-1'-yl-methanone) | Recent Studies (post-2010) ((6-chloro-1-(2-(dimethylamino)ethyl)indol-3-yl)-spiro(1h-isobenzofuran-3,4'-piperidine)-1'-yl-methanone) |
---|---|---|---|---|---|
967 | 172 | 786 | 6 | 1 | 6 |
Protein | Taxonomy | tolvaptan (IC50) | (6-chloro-1-(2-(dimethylamino)ethyl)indol-3-yl)-spiro(1h-isobenzofuran-3,4'-piperidine)-1'-yl-methanone (IC50) |
---|---|---|---|
Vasopressin V1a receptor | Homo sapiens (human) | 0.002 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Baska, F; Bata, I; Béni, Z; Bozó, É; Domány-Kovács, K; Greiner, I; Kóti, J; Krámos, B; Lévai, S; Magdó, I; Szakács, Z; Szántay, C; Szeleczky, Z; Temesvári, K; Vass, E; Vukics, K | 1 |
1 other study(ies) available for tolvaptan and (6-chloro-1-(2-(dimethylamino)ethyl)indol-3-yl)-spiro(1h-isobenzofuran-3,4'-piperidine)-1'-yl-methanone
Article | Year |
---|---|
Synthesis and Characterization of New V
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Dose-Response Relationship, Drug; Humans; Molecular Structure; Receptors, Vasopressin; Stereoisomerism; Structure-Activity Relationship | 2021 |